BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6393710)

  • 1. Role of the polysaccharide and of the lipopolysaccharide in the immunoprotective capacity of Klebsiella pneumoniae ribosomes.
    Robert D; Normier G; Lafont S; Dussourd d'Hinterland L; Fontanges R; Wigzell H
    Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):293-9. PubMed ID: 6393710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations.
    Riottot MM; Fournier JM; Jouin H
    Infect Immun; 1981 Jan; 31(1):71-7. PubMed ID: 7012008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine immunoprotective activity of Klebsiella pneumoniae cell surface preparations: comparative study with ribosomal preparations.
    Fournier JM; Jolivet-Reynaud C; Riottot MM; Jouin H
    Infect Immun; 1981 May; 32(2):420-6. PubMed ID: 7019071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribosomes as carriers for antigenic determinants of the surface of micro-organisms.
    Normier G; Pinel AM; Dussourd d'Hinterland L; Wigzell H; Binz H
    Dev Biol Stand; 1992; 77():79-85. PubMed ID: 1385236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoprotective activity of capsular polysaccharide in Klebsiella pneumoniae ribosomal preparations does not involve ribonucleic acid.
    Riottot MM; Fournier JM
    Infect Immun; 1981 Oct; 34(1):126-30. PubMed ID: 6170582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations.
    Riottot M; Fournier JM; Pillot J
    Infect Immun; 1979 May; 24(2):476-82. PubMed ID: 378855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antigenic similarity between polysaccharide and ribosomal vaccine extracts from Klebsiella pneumonia].
    Robert D; Lafont S; Bienvenu P; Normier G; Dussourd D'Hinterland L; Fontanges R
    C R Seances Acad Sci III; 1981 Jan; 292(3):281-4. PubMed ID: 6162585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An attempt to localize the vaccinating power of Klebsiella pneumoniae ribosomal preparations using saccharose-gradient ultracentrifugation.
    Robert D; Bienvenu P; Lafont S; Jouanneteau B; Normier G; Dussourd D'Hinterland L; Fontanges R
    Microbiol Immunol; 1982; 26(10):941-50. PubMed ID: 6761558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum.
    Ciurana B; Tomás JM
    Infect Immun; 1987 Nov; 55(11):2741-6. PubMed ID: 3312009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenic properties of Klebsiella pneumoniae type 2 capsular polysaccharide.
    Robert A; Jouin H; Fournier JM
    Infect Immun; 1986 Nov; 54(2):365-70. PubMed ID: 3095240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the immunogenicity of ribosomes and ribosomal proteins isolated from Klebsiella pneumoniae and Streptococcus pneumoniae.
    Robert D; Michel S; Ivanoff B; Cozzone AJ; Fontanges R
    Microbiol Immunol; 1981; 25(2):183-94. PubMed ID: 7015078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity.
    Tomás JM; Benedí VJ; Ciurana B; Jofre J
    Infect Immun; 1986 Oct; 54(1):85-9. PubMed ID: 3531020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the immunogenicity of ribosomes and ribosomal RNA extracted from K. pneumoniae and S. pneumoniae.
    Fontanges R; Robert D; Content Y; Nis G
    Arzneimittelforschung; 1980; 30(1a):142-72. PubMed ID: 6154468
    [No Abstract]   [Full Text] [Related]  

  • 14. Study of the mode of action of ribosomal vaccines from Klebsiella and Streptococcus pneumoniae and their ribonucleic and protein fractions using passive immunization.
    Robert D; Ivanoff B; Fontanges R; Normier G; Pinel AM; Dussourd D'Hinterland L
    Microbiol Immunol; 1982; 26(10):933-40. PubMed ID: 6186896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that L-rhamnose is the antigenic determinant of hyporesponsiveness of BALB/c mice to Klebsiella pneumoniae type 47.
    White-Scharf ME; Rosenberg LT
    Infect Immun; 1978 Oct; 22(1):18-21. PubMed ID: 83296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of immunoprotection against fatal experimental Klebsiella pneumoniae pneumonia].
    Shimoguchi K
    Kansenshogaku Zasshi; 1990 Dec; 64(12):1482-92. PubMed ID: 2074365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial ribosomal vaccines.
    Gregory RL
    Rev Infect Dis; 1986; 8(2):208-17. PubMed ID: 3518022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of an extracellular toxic complex by various strains of Klebsiella pneumoniae.
    Straus DC
    Infect Immun; 1987 Jan; 55(1):44-8. PubMed ID: 3539806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further Studies of the polysaccharide of Klebsiella pneumoniae possessing strong adjuvanticity. I. Production of the adjuvant polysaccharide by noncapsulated mutant.
    Ohta M; Mori M; Hasegawa T; Nagase F; Nakashima I; Naito S; Kato N
    Microbiol Immunol; 1981; 25(9):939-48. PubMed ID: 7031445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against fatal Klebsiella pneumoniae burn wound sepsis by passive transfer of anticapsular polysaccharide.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1984 Jul; 45(1):139-42. PubMed ID: 6376353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.